A study published in The American Journal of Drug and Alcohol Abuse suggests that psilocybin, the hallucinogen found in magic mushrooms, can help smokers quit smoking.
A Finnish study published online in JAMA Internal Medicine found that “found that every 500-meter (about one third of a mile) increase in distance to the nearest tobacco shop increased an individual’s odds of quitting by 20 percent to 60 percent.”
A new research indicated “an implantable pacemaker-like device that controls breathing muscles during sleep by electrical stimulation of a phrenic nerve proved effective in patients with moderate to severe central sleep apnea.”
The FDA has approved a surgically implanted weight-loss device that drains the contents of the stomach after meals. The AspireAssist device is intended for those aged 22 and older with a body mass index of 35 to 55.
Smokers are more likely to try quitting and more successful at quitting if they are given cigarette packs with graphic warnings compared to smokers given cigarette packs with only text warnings, according to a new study published in JAMA Internal Medicine.
An average of 251,454 deaths per year in the United States are caused by medical error.
Even that figure probably underestimates the actual number, because it includes only deaths in hospitals, not in out-patient surgery centers, nursing homes, or other health care settings.
Are allergy shots going out of favor. This is good news for patients and bad news for allergist who make most of their income out of allergy shots for at least 3 years. The tablets are much more convenient however the price might be very high!
In 2014, the Food and Drug Administration approved Oralair for grass allergies. It was the first sublingual allergy immunotherapy tablet approved for use in the United States. It then approved Grastek, also for grass allergies, and Ragwitek, for ragweed allergies.
Government health officials will team up with minor league baseball as part of a new $36 million campaign to discourage rural teenagers from using chewing tobacco.
About 5 percent of middle-school students reported using e-cigarettes in 2015, up from about 4 percent in 2014, according to data from the CDC and prevention. That is a substantial increase from 2011, when less than 1 percent of middle schoolers used the devices.
Similar to 2008, the USPSTF did not find evidence that screening for COPD in asymptomatic persons improves health-related quality of life, morbidity, or mortality. The USPSTF determined that early detection of COPD, before the development of symptoms, does not alter the course of the disease or improve patient outcomes. The USPSTF concludes with moderate certainty that screening for COPD in asymptomatic persons has no net benefit.
DUE TO INCLEMENT WEATHER WE WILL BE CLOSED THURSDAY THROUGH SUNDAY
01/18/24 – 01/21/24